A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure.
about
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsThe targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.Comparison of genome sequencing and clinical genotyping for pharmacogenes.Distinctiveness of the Roma population within CYP2B6 worldwide variation.Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations.
P2860
A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A comparison of DMET Plus micr ...... ssing population substructure.
@en
type
label
A comparison of DMET Plus micr ...... ssing population substructure.
@en
prefLabel
A comparison of DMET Plus micr ...... ssing population substructure.
@en
P2093
P2860
P1476
A comparison of DMET Plus micr ...... ssing population substructure.
@en
P2093
Alison A Motsinger-Reif
Howard L McLeod
Jami N Jackson
Kevin M Long
P2860
P356
10.1097/FPC.0000000000000200
P577
2016-01-01T00:00:00Z